Trial Profile
The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Sep 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Jun 2016 Status changed from recruiting to active, no longer recruiting, according to results presented at the 76th Annual Scientific Sessions of the American Diabetes Association
- 27 May 2016 New trial record